CHI-SAN TAIJIA-FENG WUHUEY-LING CHENHONG-YUAN HSUMEI-HWEI CHANGYEN-HSUAN NI2021-11-172021-11-172018-050929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/587015This study aimed to investigate the epidemiology, the preference of medication, and the potential outcome of Wilson disease in Taiwan. We aimed to provide better therapeutic options for patients with Wilson disease based on the data generated from this study.enOutcome; Taiwan; Therapy; Wilson disease[SDGs]SDG3penicillamine; trientine; zinc derivative; penicillamine; trientine; zinc; adolescent; adult; age; Article; child; clinical outcome; drug preference; end stage liver disease; female; fulminant hepatic failure; hospital patient; human; ICD-9; liver cirrhosis; liver transplantation; longitudinal study; major clinical study; male; medical record; national health insurance; outpatient department; population research; prevalence; sex ratio; Taiwan; Wilson disease; middle aged; preschool child; Wilson disease; young adult; Adolescent; Adult; Child; Child, Preschool; Female; Hepatolenticular Degeneration; Humans; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Penicillamine; Trientine; Young Adult; Zincjournal article10.1016/j.jfma.2017.05.008285789782-s2.0-85020075775https://scholars.lib.ntu.edu.tw/handle/123456789/475069